Elicio Therapeutics (ELTX) Exchange Rate Effect (2020 - 2026)
Elicio Therapeutics' (ELTX) quarterly Exchange Rate Effect came in at $5000.0 in Q1 2026, down 83.87% YoY from $31000.0 in Q1 2025, and up 105.21% on a QoQ basis from -$96000.0 in Q4 2025.
Elicio Therapeutics (ELTX) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Elicio Therapeutics (ELTX) has 7 years of Exchange Rate Effect data on file, last reported at $5000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 83.87% year-over-year to $5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22000.0 (down 58.49% YoY) and the FY2025 annual result came in at $48000.0, up 118.18% from the prior year.
- Exchange Rate Effect grew to $5000.0 in Q1 2026, from -$96000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $87000.0 in Q2 2022 to a low of -$96000.0 in Q4 2025.
- A 5-year average of $5769.2 and a median of $27000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 2800.0% — and 2024, when it soared 1700.0%.
- Tracing ELTX's Exchange Rate Effect over 5 years: stood at $87000.0 in 2022, then sank by 97.7% to $2000.0 in 2023, then jumped by 1250.0% to $27000.0 in 2024, then tumbled by 455.56% to -$96000.0 in 2025, then surged by 105.21% to $5000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $5000.0 (Q1 2026), -$96000.0 (Q4 2025), and $39000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Elicio Therapeutics | 59.08 Mn | 35.58 Mn | - | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,000.00 |
| Jun 30, 2026 | -4,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | -96,000.00 |
| Dec 31, 2025 | -96,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |